Brief: Viva Biotech Holdings Expects Net Profit Of RMB210 Million To RMB240 Million For 2024
13/03/2025 13:21
March 13 (Reuters) - VIVA Biotech Holdings 1873.HK: EXPECTS NET PROFIT OF RMB210 MILLION TO RMB240 MILLION FOR 2024 NET PROFIT ATTRIBUTABLE EXPECTED TO BE RMB150 MILLION TO RMB180 MILLION FOR YEAR Further company coverage: 1873.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical